Tags: Drug.
AC-262356 is a drug developed by Acadia Pharmaceuticals which acts as a selective androgen receptor modulator. It acts as a partial agonist for the androgen receptor with a Ki of 5nM and no significant affinity for any other receptors tested. In animal studies it produced a maximal effect of around 66% of the anabolic action of testosterone but only around 27% of its potency as an androgen.
